BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21272161)

  • 1. c-Jun N-terminal kinase activation by oxidative stress suppresses retinoid signaling through proteasomal degradation of retinoic acid receptor α protein in hepatic cells.
    Hoshikawa Y; Kanki K; Ashla AA; Arakaki Y; Azumi J; Yasui T; Tezuka Y; Matsumi Y; Tsuchiya H; Kurimasa A; Hisatome I; Hirano T; Fujimoto J; Kagechika H; Shomori K; Ito H; Shiota G
    Cancer Sci; 2011 May; 102(5):934-41. PubMed ID: 21272161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.
    Singh AB; Guleria RS; Nizamutdinova IT; Baker KM; Pan J
    J Cell Physiol; 2012 Jun; 227(6):2632-44. PubMed ID: 21882190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Jun N-terminal kinase contributes to aberrant retinoid signaling in lung cancer cells by phosphorylating and inducing proteasomal degradation of retinoic acid receptor alpha.
    Srinivas H; Juroske DM; Kalyankrishna S; Cody DD; Price RE; Xu XC; Narayanan R; Weigel NL; Kurie JM
    Mol Cell Biol; 2005 Feb; 25(3):1054-69. PubMed ID: 15657432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect.
    Xu Q; Konta T; Furusu A; Nakayama K; Lucio-Cazana J; Fine LG; Kitamura M
    J Biol Chem; 2002 Nov; 277(44):41693-700. PubMed ID: 12186877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid-induced blr1 expression requires RARalpha, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation.
    Battle TE; Roberson MS; Zhang T; Varvayanis S; Yen A
    Eur J Cell Biol; 2001 Jan; 80(1):59-67. PubMed ID: 11211936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation of the retinoid x receptor at the omega loop, modulates the expression of retinoic-acid-target genes with a promoter context specificity.
    Bruck N; Bastien J; Bour G; Tarrade A; Plassat JL; Bauer A; Adam-Stitah S; Rochette-Egly C
    Cell Signal; 2005 Oct; 17(10):1229-39. PubMed ID: 16038797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARalpha and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways.
    Hughes PJ; Zhao Y; Chandraratna RA; Brown G
    J Cell Biochem; 2006 Feb; 97(2):327-50. PubMed ID: 16178010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta-mediated suppression of RXR:RAR transactivation of the Ntcp promoter is JNK-dependent.
    Li D; Zimmerman TL; Thevananther S; Lee HY; Kurie JM; Karpen SJ
    J Biol Chem; 2002 Aug; 277(35):31416-22. PubMed ID: 12105223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
    Duprez E; Lillehaug JR; Gaub MP; Lanotte M
    Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of RXR alpha during activation of cycling human T lymphocytes: modulation of RXRE transactivation function by mitogen-activated protein kinase pathways.
    Ishaq M; Fan M; Natarajan V
    J Immunol; 2000 Oct; 165(8):4217-25. PubMed ID: 11035054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans-retinoic acid inhibits Jun N-terminal kinase-dependent signaling pathways.
    Lee HY; Walsh GL; Dawson MI; Hong WK; Kurie JM
    J Biol Chem; 1998 Mar; 273(12):7066-71. PubMed ID: 9507016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells.
    Turner NA; Xia F; Azhar G; Zhang X; Liu L; Wei JY
    J Mol Cell Cardiol; 1998 Sep; 30(9):1789-801. PubMed ID: 9769235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Otto KB; Acharya SS; Robinson VL
    Urol Oncol; 2012; 30(4):415-20. PubMed ID: 22154358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acids acting through retinoid receptors protect hippocampal neurons from oxygen-glucose deprivation-mediated cell death by inhibition of c-jun-N-terminal kinase and p38 mitogen-activated protein kinase.
    Shinozaki Y; Sato Y; Koizumi S; Ohno Y; Nagao T; Inoue K
    Neuroscience; 2007 Jun; 147(1):153-63. PubMed ID: 17521827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
    Boudjelal M; Voorhees JJ; Fisher GJ
    Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of retinoic acid receptor isotypes alpha, beta, and gamma during the initial steps of neural differentiation of PCC7 cells.
    Zechel C
    Mol Endocrinol; 2005 Jun; 19(6):1629-45. PubMed ID: 15831518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and metabolic retinoid pathways in the human ocular surface.
    Nezzar H; Chiambaretta F; Marceau G; Blanchon L; Faye B; Dechelotte P; Rigal D; Sapin V
    Mol Vis; 2007 Sep; 13():1641-50. PubMed ID: 17893666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
    Peng X; Yun D; Christov K
    Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
    He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
    Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
    Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H
    Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.